HHS: Trump's plan for drug prices does have more negotiations

HHS Secretary Alex Azar briefs reporters at the White House.
HHS Secretary Alex Azar. Photo: Sarah Silbiger/CQ Roll Call via Getty Images

Health and Human Services Secretary Alex Azar said today that the Trump administration's plan for lowering drug costs relies on expanded price negotiations — just not the kind Democrats have called for in the past, and which President Trump seemed to embrace during the campaign.

The catch: The administration's plan would pull more drugs into an existing system of price negotiations within Medicare. But it’s not clear how many drugs would be affected or how much of that shift the administration could make on its own, without help from Congress.